Peter M. Irving

456 citations
12 papers · 186 indexed · 1 hit paper · h-index 3

Peter M. Irving

9 papers receiving 180 citations

Hit Papers

Mirikizumab as Induction and Maintenance Therapy for Ulce...2023202620242025202350100150

Peers

Peter M. Irving
Comparison fields: 5 of 28
  • Genetics 162
  • Epidemiology 121
  • Immunology 51
  • Surgery 45
  • Gastroenterology 22
Replace Claire Liefferinckx with:
Claire Liefferinckx Belgium
Marijana Protić United States
Laurent Peyrin-Biroulet France
Laura Loy Italy
Alexandros Skamnelos Greece
Luisa de Castro Spain
Joseph Delo United Kingdom
Beata Gawdis-Wojnarska Germany
Marina Leoni Italy
Laura Cantoro Italy
Peter M. Irving relative to Claire Liefferinckx Belgium Claire Liefferinckx's profile →
Citations per field
00.5×
Claire Liefferinckx · 1×
Citations per year

Countries citing papers authored by Peter M. Irving

Since Specialization
Citations

This map shows the geographic impact of Peter M. Irving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Irving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Irving more than expected).

Fields of papers citing papers by Peter M. Irving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Irving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Irving. The network helps show where Peter M. Irving may publish in the future.

Co-authorship network of co-authors of Peter M. Irving

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Irving. A scholar is included among the top collaborators of Peter M. Irving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Irving. Peter M. Irving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 3
2 0
3 1
4 0
5
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitisbreakdown →
170
6 0
7 1
8 1
9 1
10 7
11 1
12 1

About Peter M. Irving

Peter M. Irving is a scholar working on Gastroenterology, Hepatology and Genetics, having authored 12 papers that have together received 186 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (6 papers) and Liver Diseases and Immunity (3 papers). The work is most often cited by research in Genetics (162 citations), Gastroenterology (22 citations) and Epidemiology (121 citations). Peter M. Irving has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Xingyuan Li, Janelle Laskowski, Geert D’Haens, Nathan Morris, Juris Pokrotnieks, Joe Milata, William J. Sandborn, Catherine Milch, Marla C. Dubinsky and Vipin Arora. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026